ENTERPRISE FINANCIAL SERVICES CORP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ENTERPRISE FINANCIAL SERVICES CORP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2021$21,000
-19.2%
4100.0%0.00%0.0%
Q3 2021$26,000
-13.3%
4100.0%0.00%
-40.0%
Q2 2021$30,0000.0%4100.0%0.01%0.0%
Q1 2021$30,0000.0%4100.0%0.01%
-16.7%
Q4 2020$30,000
+36.4%
4100.0%0.01%
+20.0%
Q3 2020$22,000
-18.5%
4100.0%0.01%
-16.7%
Q2 2020$27,000
+8.0%
4100.0%0.01%0.0%
Q1 2020$25,000
-30.6%
4100.0%0.01%
-25.0%
Q4 2019$36,000
+16.1%
4100.0%0.01%
+14.3%
Q3 2019$31,000
-11.4%
4100.0%0.01%
-12.5%
Q2 2019$35,000
-20.5%
4100.0%0.01%
-20.0%
Q1 2019$44,000
+780.0%
410
+831.8%
0.01%
+400.0%
Q4 2017$5,0000.0%440.0%0.00%0.0%
Q3 2017$5,0000.0%440.0%0.00%0.0%
Q2 2017$5,00044
+1000.0%
0.00%
Q1 2017$0
-100.0%
4
-86.7%
0.00%
-100.0%
Q4 2016$3,000300.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders